BruceL.GilliamMD
Infectious Disease • Baltimore, MDHIV/AIDS Medicine, International Health, Travel & Tropical
Head, U.S. Medical and Strategic Operations, ViiV Healthcare, Clinical Professor of Medicine, University of Maryland School of Medicine
Dr. Gilliam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Armory Pl
Fl 1
Baltimore, MD 21201Phone+1 410-225-8369Fax+1 410-706-1992
Education & Training
University of North Carolina HospitalsFellowship, Infectious Disease, 1993 - 1996
University of California Davis HealthResidency, Internal Medicine, 1990 - 1993
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1990
Certifications & Licensure
CA State Medical License 1991 - 2026
MD State Medical License 1996 - 2026
NC State Medical License 1993 - 2000- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV Start of enrollment: 2015 Aug 01
- A Safety and Immunogenicity Trial of IHV01 Start of enrollment: 2015 Nov 01
Publications & Presentations
PubMed
- 10 citationsSuccessful treatment with atazanavir and lopinavir/ritonavir combination therapy in protease inhibitor-susceptible and protease inhibitor-resistant HIV-infected patients.Bruce L. Gilliam, Kirk M. Chan-Tack, Roula B. Qaqish, Richard A. Rode, Lori E. Fantry
AIDS Patient Care and Stds. 2006-11-29 - 53 citationsImplementation of an Infectious Disease Fellow-Managed Penicillin Allergy Skin Testing ServiceEmily L. Heil, Jacqueline Bork, Sarah A. Schmalzle, Michael Kleinberg, Anupama Kewalramani
Open Forum Infectious Diseases. 2015-10-10 - 71 citationsDalbavancin use in vulnerable patients receiving outpatient parenteral antibiotic therapy for invasive gram-positive infections.Jacqueline T. Bork, Emily L. Heil, Shanna Berry, Eurides Lopes, Rohini Dave
Infectious Diseases and Therapy. 2019-05-03
Professional Memberships
- Fellow
- Infectious Diseases Society of AmericaMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
